151 related articles for article (PubMed ID: 31928548)
21. Transcatheter closure of post-operative type 1 Gerbode defect by Amplatzer Duct Occluder 2.
Kavurt AV; Ece İ; Bağrul D
Cardiol Young; 2021 Sep; 31(9):1545-1547. PubMed ID: 34154689
[TBL] [Abstract][Full Text] [Related]
22. Transcatheter closure of atrial septal defect with the Figulla(®) ASD Occluder: a comparative study with the Amplatzer(®) Septal Occluder.
Godart F; Houeijeh A; Recher M; Francart C; Polge AS; Richardson M; Cajot MA; Duhamel A
Arch Cardiovasc Dis; 2015 Jan; 108(1):57-63. PubMed ID: 25453168
[TBL] [Abstract][Full Text] [Related]
23. Comparison of the results of transcatheter closure of patent ductus arteriosus with newer Amplatzer devices.
Liddy S; Oslizlok P; Walsh KP
Catheter Cardiovasc Interv; 2013 Aug; 82(2):253-9. PubMed ID: 23427043
[TBL] [Abstract][Full Text] [Related]
24. Transcatheter closure of hemodynamic significant patent ductus arteriosus in 32 premature infants by amplatzer ductal occluder additional size-ADOIIAS.
Morville P; Akhavi A
Catheter Cardiovasc Interv; 2017 Oct; 90(4):612-617. PubMed ID: 28471089
[TBL] [Abstract][Full Text] [Related]
25. Transcatheter closure of residual aortopulmonary septal defect.
Baruteau AE
Ann Thorac Surg; 2014 Aug; 98(2):729. PubMed ID: 25087807
[No Abstract] [Full Text] [Related]
26. Percutaneous closure of perimembranous ventricular septal defects utilizing almost ideal Amplatzer Duct Occluder II: Why limitation in sizes?
Esmaeili A; Behnke-Hall K; Schrewe R; Schranz D
Congenit Heart Dis; 2019 May; 14(3):389-395. PubMed ID: 30561883
[TBL] [Abstract][Full Text] [Related]
27. Off-label use of duct occluder in transcatheter closure of secundum atrial septal defect with no rim to right pulmonary vein.
Yan C; Li S; Song H; Jin J; Zheng H; Wang C; Zhao S
J Thorac Cardiovasc Surg; 2019 Apr; 157(4):1603-1608. PubMed ID: 30712912
[TBL] [Abstract][Full Text] [Related]
28. Off-label use of duct occluder devices to close hemodynamically significant perimembranous ventricular septal defects: A multicenter experience.
Udink Ten Cate FEA; Sobhy R; Kalantre A; Sachdev S; Subramanian A; Koneti NR; Kumar RK; Hamza H; Jayranganath M; Sreeram N
Catheter Cardiovasc Interv; 2019 Jan; 93(1):82-88. PubMed ID: 30208249
[TBL] [Abstract][Full Text] [Related]
29. Retrograde transcatheter closure of ventricular septal defects in children using the Amplatzer Duct Occluder II.
Koneti NR; Penumatsa RR; Kanchi V; Arramraj SK; S J; Bhupathiraju S
Catheter Cardiovasc Interv; 2011 Feb; 77(2):252-9. PubMed ID: 20578168
[TBL] [Abstract][Full Text] [Related]
30. Closure of the patent ductus arteriosus with the Amplatzer Duct Occluder II: a clinical experience.
Karagöz T; Akin A; Ertuğrul I; Aykan HH; Alehan D; Ozer S; Ozkutlu S
Acta Cardiol; 2012 Dec; 67(6):675-80. PubMed ID: 23393938
[TBL] [Abstract][Full Text] [Related]
31. Early clinical experience with the new Amplatzer Ductal Occluder II for closure of the persistent arterial duct.
Forsey J; Kenny D; Morgan G; Hayes A; Turner M; Tometzki A; Martin R
Catheter Cardiovasc Interv; 2009 Oct; 74(4):615-23. PubMed ID: 19360878
[TBL] [Abstract][Full Text] [Related]
32. Transcatheter closure of ventricular septal defect with Occlutech Duct Occluder.
Atik-Ugan S; Saltik IL
Cardiol Young; 2018 Apr; 28(4):598-601. PubMed ID: 29513202
[TBL] [Abstract][Full Text] [Related]
33. Transcatheter closure of doubly committed subarterial ventricular septal defects with the Amplatzer ductal occluder: initial experience.
Huang Y; Yan X; Lu L; Fang J; Sun X; Zhong L; Li J; Chen L
Cardiol Young; 2019 May; 29(5):570-575. PubMed ID: 30968785
[TBL] [Abstract][Full Text] [Related]
34. Transcatheter closure of late-onset residual aortopulmonary septal defect using a muscular ventricular septal occluder.
Li X; Zhu D; Feng Y
Int Heart J; 2014; 55(1):89-91. PubMed ID: 24463917
[TBL] [Abstract][Full Text] [Related]
35. Complete heart block following transcatheter closure of perimembranous VSD using amplatzer duct occluder II.
Ghosh S; Sridhar A; Sivaprakasam M
Catheter Cardiovasc Interv; 2018 Nov; 92(5):921-924. PubMed ID: 28707408
[TBL] [Abstract][Full Text] [Related]
36. Feasibility of transcatheter closure in unselected patients with secundum atrial septal defect, using Amplatzer devices and a modified sizing balloon technique.
Kammache I; Mancini J; Ovaert C; Habib G; Fraisse A
Catheter Cardiovasc Interv; 2011 Nov; 78(5):665-74. PubMed ID: 21812090
[TBL] [Abstract][Full Text] [Related]
37. Closure of aorto-right ventricular tunnel with Amplatzer duct occluder II.
Vijayalakshmi IB; Narasimhan C; Agarwal A
J Invasive Cardiol; 2013 Apr; 25(4):E75-7. PubMed ID: 23549501
[TBL] [Abstract][Full Text] [Related]
38. Ventricular septal defect closure in a small children with the Amplatzer Duct Occluder II.
El Tahlawi M; Kammache I; Fraisse A
Catheter Cardiovasc Interv; 2011 Feb; 77(2):268-71. PubMed ID: 21290557
[TBL] [Abstract][Full Text] [Related]
39. Perimembranous Ventricular Septal Defect Device Closure: Choosing Between Amplatzer Duct Occluder I and II.
El-Sisi A; Sobhy R; Jaccoub V; Hamza H
Pediatr Cardiol; 2017 Mar; 38(3):596-602. PubMed ID: 28251252
[TBL] [Abstract][Full Text] [Related]
40. Transcatheter closure of perimembranous ventricular septal defects using amplatzer asymmetric ventricular septal defect occluder: preliminary experience with 18-month follow up.
Pinto RJ; Dalvi BV; Sharma S
Catheter Cardiovasc Interv; 2006 Jul; 68(1):145-52. PubMed ID: 16763998
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
